BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update

—Q2 2024 ORLADEYO net revenue grows 34 percent y-o-y to $108.3 million—

—Full-year 2024 ORLADEYO revenue guidance increased to $420-$435 million (previously $390-$400 million)—